Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

Scroll to Top